HIGHLIGHTS
- who: Josu00e9 Luis Ferreiro from the Agostino Gemelli University Polyclinic (IRCCS), Italy have published the Article: Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation, in the Journal: (JOURNAL) of 22/Nov/2022
- what: The aim of this investigation was to compare the pharmacodynamic effectiveness of ticagrelor and clopidogrel in Mediterranean DM patients with CCS. The primary endpoint of this study was the comparison of MPA measured with LTA (20 u00b5M ADP as agonist) and achieved after 1 week of therapy with ticagrelor or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.